Molecular Epidemiology and Predictive Markers in Cancer Group

Group leader

Alfredo Carrato Mena

acarrato(ELIMINAR)@telefonica.net

Tlf.: +34 91 336 90 64

Principal Investigators

  • Pilar Garrido López
  • María Ángeles Vaz Salgado
  • Cristina Peña Maroto

Collaborators

  • Teresa Alonso Gordoa
  • Julie Earl
  • María Reyes Ferreiro Monteagudo
  • Eva María Guerra Ália
  • Carmen Guillén Ponce
  • Federico Longo Muñoz
  • Elena López Miranda
  • Noelia Martínez Jáñez
  • Mª Eugenia Olmedo García
  • Vanessa Pachón Olmos
  • Ainara Soria Rivas
  • Mercedes Rodríguez Garrote
  • Maria Fernandez Abad
  • Pablo Gajate Borau
  • Natalia Guerra Pérez
  • Ana Gómez Rueda
  • Sara Navarro Ruiz
  • Javier Molina Cerrillo
  • Maria Encarnación Castillo Sanchez
  • Cristina Galindo Pumariño
Imagen equipo

Group leader

Alfredo Carrato Mena

acarrato(ELIMINAR)@telefonica.net

Tlf.: +34 91 336 90 64

Principal Investigators

  • Pilar Garrido López
  • María Ángeles Vaz Salgado
  • Cristina Peña Maroto

Collaborators

  • Teresa Alonso Gordoa
  • Julie Earl
  • María Reyes Ferreiro Monteagudo
  • Eva María Guerra Ália
  • Carmen Guillén Ponce
  • Federico Longo Muñoz
  • Elena López Miranda
  • Noelia Martínez Jáñez
  • Mª Eugenia Olmedo García
  • Vanessa Pachón Olmos
  • Ainara Soria Rivas
  • Mercedes Rodríguez Garrote
  • Maria Fernandez Abad
  • Pablo Gajate Borau
  • Natalia Guerra Pérez
  • Ana Gómez Rueda
  • Sara Navarro Ruiz
  • Javier Molina Cerrillo
  • Maria Encarnación Castillo Sanchez
  • Cristina Galindo Pumariño

Strategic objectives

  • Focus on collaborations with national and international research teams of excellence through joint projects in our group's areas of interest.
  • Strengthen the active participation in international projects.
  • Increase the number of clinical trials, especially early phase trials, in strategic areas.
  • Attract researchers who enable emerging areas of interest to be consolidated

Research lines

  • Pancreatic cancer, with special interest in the phenotypical and molecular characterisation of familial pancreatic adenocarcinoma and its predisposing pathologies.
  • Identification of prognostic and predictive factors of the efficacy of antineoplastic treatments for solid tumours, with special interest in lung, colon, genitourinary and breast cancer.

Location

Medical Oncology Service


Ramón y Cajal University Hospital
-2 floor right

Keywords

lung cancer, pancreatic cancer, colon cancer, breast cancer, urologic cancer, biomarkers.